ERCC1 as a Biomarker for Bladder Cancer Patients Likely to Benefit From Adjuvant Chemotherapy
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-12-187
Full Text
Open PDFAbstract
Available in full text
Date
May 22, 2012
Authors
Publisher
Springer Science and Business Media LLC